Alzheimer’s disease (AD) is a neurodegenerative disease characterized by progressive
cognitive impairment and neuroinflammation. Recent research has revealed the crucial role of …

Accumulating evidence from animal studies supports the potential role of probiotics and
prebiotics in alleviating neurodegenerative diseases. However, whether dietary …

Alzheimer’s disease (AD) is a neurodegenerative disease, pathological markers of which
are amyloid plaques and neurofibrillary tangles. As a key node of gut–brain axis, gut …

Psychobiotics are used to treat neurological disorders, including mild cognitive impairment (MCI)
and Alzheimer’s disease (AD). However, the mechanisms underlying their …

Alzheimer’s disease (AD) is commonly accompanied by global alterations in metabolic
profiles, resulting in cognitive impairment and neuroinflammation in the brain. Using …

Host gut microbiota dysbiosis occurs for multiple reasons and is often accompanied by
chronic inflammation induced by a high-fat–high-sucrose (HFHS) diet and related metabolic …

Alzheimer’s disease (AD) is characterized by behavioral and cognitive impairments and its
increasing prevalence imposes a healthcare burden on society. To date, most intervention …

Selenium is one of the essential trace elements in human body, however, due to the limitation
of geographic factors, the intake of selenium is seriously insufficient in most regions. In this …

The gut microbiota-brain axis has emerged as a novel target for Alzheimer’s disease (AD), a
neurodegenerative disease characterised by behavioural and cognitive impairment. …

Purpose: To investigate the regulatory effect of Lactobacillus plantarum on metabolic
syndrome induced by high-fat-high-sucrose (HFHS) diet in rats and its possible mechanism of …